Title
Category
Credits
Event date
Cost
Clinical Brief: Advancements in Dyslipidemia Treatments and ASCVD Risk Reduction for High-Risk Individuals
  • CMHC
  • 0.50 ACPE Pharmacy
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 CDE
  • 0.50 Participation
$0.00
This clinical brief was developed from a presentation at the 19th CMHC Annual Congress held from October 17-19, 2024 in Boston, MA. The session, “Evolving Therapies in Dyslipidemia and ASCVD Risk Reduction: Putting It All Together in High-Risk Patients,” was presented by Dr. Pamela B. Morris, Professor of Medicine, Cardiology from The Medical University of South Carolina, Charleston, SC, supported by an educational grant from Esperion Therapeutics.
Navigating Cardiorenal Metabolic Complexities: A Case Study of a 64-Year-Old Female with T2D, HTN, CKD, and Obesity
  • CMHC
  • 0.50 ACPE Pharmacy
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.50 CDE
  • 0.50 Participation
$0.00
This interactive case-based program focuses on managing patients with cardiorenal metabolic comorbidities. Participants will explore evidence-based guidelines, therapeutic strategies, and risk assessment tools to improve cardiovascular and kidney outcomes in patients with CKD, type 2 diabetes, and cardiovascular disease. Engaging decision-making scenarios and expert-led discussions will enhance practical skills and interdisciplinary approaches to optimize patient care.

Pages